BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 1381807)

  • 1. Prostate specific antigen.
    Med Lett Drugs Ther; 1992 Oct; 34(880):93-4. PubMed ID: 1381807
    [No Abstract]   [Full Text] [Related]  

  • 2. Measurement of prostate-specific antigen in serum as a screening test for prostate cancer.
    Catalona WJ; Smith DS; Ratliff TL; Dodds KM; Coplen DE; Yuan JJ; Petros JA; Andriole GL
    N Engl J Med; 1991 Apr; 324(17):1156-61. PubMed ID: 1707140
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Importance of specific prostatic antigen to prostatic volume ratio in the selection of patients for ultrasonography-guided biopsy of the prostate].
    Veneziano S; Pavlica P; Querzè R; Viglietta G; Trenta A
    Radiol Med; 1991 Jun; 81(6):857-60. PubMed ID: 1713333
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serum prostate-specific antigen: the most useful tumor marker.
    Andriole GL
    J Clin Oncol; 1992 Aug; 10(8):1205-7. PubMed ID: 1378885
    [No Abstract]   [Full Text] [Related]  

  • 5. [Detection of localized prostatic cancer Paris, December 8 and 9, 1989].
    Richard F
    Rev Prat; 1990 Sep; 40(20):1872-4. PubMed ID: 1699263
    [No Abstract]   [Full Text] [Related]  

  • 6. Prostate-specific antigen. Improving its ability to diagnose early prostate cancer.
    Oesterling JE
    JAMA; 1992 Apr 22-29; 267(16):2236-8. PubMed ID: 1372945
    [No Abstract]   [Full Text] [Related]  

  • 7. [The diagnosis of prostatic carcinoma].
    Hammerer P; Huland H
    Fortschr Med; 1991 Sep; 109(26):512-7. PubMed ID: 1723711
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Usefulness of bone gammagraphy versus tumor markers (PSA/PAP) in monitoring cancer of the prostate].
    Morote J; de Torres JA
    Actas Urol Esp; 1990; 14(4):268-70. PubMed ID: 1702258
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diagnosis of prostate cancer: a personal view.
    Stamey TA
    J Urol; 1992 Mar; 147(3 Pt 2):830-2. PubMed ID: 1371556
    [No Abstract]   [Full Text] [Related]  

  • 10. Clinical application of transrectal ultrasonography and prostate specific antigen in the search for prostate cancer.
    Cooner WH; Mosley BR; Rutherford CL; Beard JH; Pond HS; Bass RB; Terry WJ
    J Urol; 1988 Apr; 139(4):758-61. PubMed ID: 2451035
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Cancer of the prostate: current diagnostic aspects].
    Sanz Velez JI; Gil Sanz MJ; Allepuz Losa C; Rioja Sanz LA
    Actas Urol Esp; 1991; 15(6):518-26. PubMed ID: 1724346
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Re: The added value of percentage of free to total prostate-specific antigen, PCA3, and a kallikrein panel to the ERSPC risk calculator for prostate cancer in prescreened men.
    Taneja SS
    J Urol; 2015 Jan; 193(1):127. PubMed ID: 25523657
    [No Abstract]   [Full Text] [Related]  

  • 13. Digital rectal examination-associated alterations in serum prostate-specific antigen.
    Gillenwater JY
    Am J Clin Pathol; 1992 Apr; 97(4):466-7. PubMed ID: 1372786
    [No Abstract]   [Full Text] [Related]  

  • 14. Early detection of stage A prostate carcinoma: combined use of prostate-specific antigen and transrectal ultrasonography.
    Fiorelli RL; Klaus RL; Manfrey SJ; Belkoff LH; Finkelstein LH
    J Am Osteopath Assoc; 1991 Sep; 91(9):863-70. PubMed ID: 1721900
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Early diagnosis of prostate cancer].
    Hocaoglu Y; Seitz M; Stief CG; Bastian PJ
    MMW Fortschr Med; 2012 Jan; 154(1):43-6. PubMed ID: 22642003
    [No Abstract]   [Full Text] [Related]  

  • 16. Diagnosis and markers in prostate cancer.
    Flam TA; Brawer MK; Cooper EH; Javadpour N
    Cancer; 1992 Jul; 70(1 Suppl):357-8. PubMed ID: 1376206
    [No Abstract]   [Full Text] [Related]  

  • 17. Will emerging prostate cancer markers redeem themselves?
    Hotakainen K; Stenman UH
    Clin Chem; 2010 Aug; 56(8):1212-3. PubMed ID: 20570933
    [No Abstract]   [Full Text] [Related]  

  • 18. Researchers look to MRI and biomarkers to help improve detection of aggressive prostate cancers.
    Rubin R
    JAMA; 2015 Feb; 313(7):654-6. PubMed ID: 25629168
    [No Abstract]   [Full Text] [Related]  

  • 19. Re: Prostate specific antigen in the diagnosis and treatment of adenocarcinoma of the prostate.
    McVary KT; Rademaker AW
    J Urol; 1990 Dec; 144(6):1485-6. PubMed ID: 1700159
    [No Abstract]   [Full Text] [Related]  

  • 20. [Diagnosis of prostate cancer].
    Kaprin AD; Anan'ev AP; Amosov FR; Gafanov RA
    Vopr Onkol; 1999; 45(1):20-5. PubMed ID: 10941360
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.